How Fully Private, No-Insurance Hospitals Help the Common Man
The standard line with progressives is that unless government controls medical care, prices will skyrocket. But what if the free market model costs less than government-directed care?
The standard line with progressives is that unless government controls medical care, prices will skyrocket. But what if the free market model costs less than government-directed care?
The Biden administration in its desire to "save" the planet from climate change has decided to destroy one of this country's most productive and important industries in the process, putting the US economy itself in jeopardy.
The standard bureaucratic line after a program's failure is that the government agents didn't have enough authority or resources to handle the job. Neither explains the failure of Trump's Paycheck Protection Program.
The agriculture industry is largely running as a planned economy. When the power to make decisions is delegated to bureaucrats rather than to those impacted, mismanagement is a given.
The standard bureaucratic line after a program's failure is that the government agents didn't have enough authority or resources to handle the job. Neither explains the failure of Trump's Paycheck Protection Program.
States continue to seek new ways to make the financial system an “economic chokepoint” enabling the state to crack down on specific organizations, individuals, or activities.
F.A. Hayek wrote that the "worst get on top" when it comes to government. Nearly eighty years after he wrote those words, nothing has changed.
All too often, people accept the state-sponsored "solution" to a perceived problem as the logical choice. But this "solution" really is a non sequitur.
States continue to seek new ways to make the financial system an “economic chokepoint” enabling the state to crack down on specific organizations, individuals, or activities.
While government officials and politicians denounce high drug prices, they have created monopoly privileges for drug firms, thus ensuring higher-than-competitive prices for pharmaceuticals.